Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆

Search Results

Found 172 results for "Merck" across articles, medicines, trials, companies and the glossary

MedicinesAll 161 →

Bavencio 20 mg/mL concentrate for solution for infusionAvelumab · Merck Europe B.V. Bridion 100 mg/ml solution for injectionSugammadex · Merck Sharp & Dohme BV Campral EC 333mg Gastro-resistant tabletsAcamprosate calcium · Merck Serono (Ireland) Limited Cancidas 50 mg powder for concentrate for solution for infusionCaspofungin · Merck Sharp & Dohme BV Cancidas 70 mg powder for concentrate for solution for infusionCaspofungin · Merck Sharp & Dohme BV CAPVAXIVE solution for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (21-valent)Pneumococcal Polysaccharide Serotype 3 Conjugated to CRM197, Pneumococcal Polysaccharide Serotype 6A Conjugated to CRM197, Pneumococcal polysaccharide serotype 7F conjugated to CRM197, Pneumococcal polysaccharide serotype 8 conjugated to CRM197, Pneumococcal polysaccharide serotype 9N conjugated to CRM197 · Merck Sharp & Dohme BV,

Clinical trials in IrelandTracker →

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus…Active · Merck Sharp & Dohme LLC Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for H…Active · Merck Sharp & Dohme LLC A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatini…Active · Merck Sharp & Dohme LLC Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who A…Recruiting · Merck Sharp & Dohme LLC

CompaniesDirectory →

Merck KGaAPharmaceutical · Darmstadt Merck & Co.Pharmaceutical · Rahway, NJ

US Pharma Resume Guide 2026: FDA cGMP Standards, ATS Formats & Free Builder

US Pharma Resume Guide 2026: FDA cGMP Standards, ATS Formats & Free Builder

Master the US pharmaceutical resume format in 2026. Covers FDA 21 CFR compliance terms, 1-2 page US resume rules, major US biopharma hubs (Boston, SF Bay, NJ, NC Triangle), and free ATS resume tools.

Ireland's Biopharma Manufacturing Hub: A Master Guide to Tax, Talent, CDMO Sourcing, and Regulatory Excellence

Ireland's Biopharma Manufacturing Hub: A Master Guide to Tax, Talent, CDMO Sourcing, and Regulatory Excellence

An in-depth analysis of Ireland's evolution into Europe's second-largest exporter of medicinal products. Discover how a 12.5% tax structure, NIBRT bioprocessing excellence, HPRA regulatory trust, and a thriving CDMO ecosystem make Ireland the premier location for global drug production.

Global Biopharma M&A Rebounds in 2026: AbbVie and Merck KGaA Lead Multi-Billion Dollar Acquisitions

Global Biopharma M&A Rebounds in 2026: AbbVie and Merck KGaA Lead Multi-Billion Dollar Acquisitions

Global pharmaceutical dealmaking has surged in 2026 as cash-rich majors AbbVie and Merck KGaA close multi-billion dollar acquisitions to restock pipelines ahead of late-decade patent cliffs.

The 2026 Obesity Power Rankings: Which Pharma Giants Can Break the Lilly-Novo Duopoly?

Clinical Trials

The 2026 Obesity Power Rankings: Which Pharma Giants Can Break the Lilly-Novo Duopoly?

With the obesity market projected to exceed $130 billion by 2034, we analyze the top 10 pharmaceutical companies vying for dominance. Explore our comprehensive Power Rankings assessing pipeline depth, clinical differentiation, and commercial infrastructure.

A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&A Surge

A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&A Surge

An in-depth analysis of the massive wave of pharmaceutical mergers and acquisitions in the first half of 2026, driven by patent cliffs, pipeline replenishment, and high-growth therapeutic areas.